GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cosciens Biopharma Inc (TSX:CSCI) » Definitions » Market Cap

Cosciens Biopharma (TSX:CSCI) Market Cap : C$14.06 Mil (As of Mar. 27, 2025)


View and export this data going back to 1992. Start your Free Trial

What is Cosciens Biopharma Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cosciens Biopharma's share price for the quarter that ended in Sep. 2024 was C$5.03. Cosciens Biopharma's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 3.12 Mil. Therefore, Cosciens Biopharma's market cap for the quarter that ended in Sep. 2024 was C$15.70 Mil.

Cosciens Biopharma's quarterly market cap increased from Mar. 2024 (C$18.40 Mil) to Jun. 2024 (C$18.59 Mil) but then declined from Jun. 2024 (C$18.59 Mil) to Sep. 2024 (C$15.70 Mil).

Cosciens Biopharma's annual market cap declined from Dec. 2021 (C$47.38 Mil) to Dec. 2022 (C$46.15 Mil) and declined from Dec. 2022 (C$46.15 Mil) to Dec. 2023 (C$14.88 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cosciens Biopharma's Enterprise Value for Today is C$-12.19 Mil.


Cosciens Biopharma Market Cap Historical Data

The historical data trend for Cosciens Biopharma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosciens Biopharma Market Cap Chart

Cosciens Biopharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.75 51.23 47.38 46.15 14.88

Cosciens Biopharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.97 14.88 18.40 18.59 15.70

Competitive Comparison of Cosciens Biopharma's Market Cap

For the Biotechnology subindustry, Cosciens Biopharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosciens Biopharma's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cosciens Biopharma's Market Cap distribution charts can be found below:

* The bar in red indicates where Cosciens Biopharma's Market Cap falls into.


;
;

Cosciens Biopharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Cosciens Biopharma's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=C$8.050847*1.848
=C$14.88

Cosciens Biopharma's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=C$5.03*3.122
=C$15.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cosciens Biopharma  (TSX:CSCI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Cosciens Biopharma Market Cap Related Terms

Thank you for viewing the detailed overview of Cosciens Biopharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosciens Biopharma Business Description

Traded in Other Exchanges
Address
c/o Norton Rose Fulbright Canada LLP, 222 Bay Street, Suite 3000, Toronto, ON, CAN, M5K 1E7
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.
Executives
Dennis Turpin Director
Gilles Gagnon Director

Cosciens Biopharma Headlines